Error message

  • Deprecated function: Unparenthesized `a ? b : c ? d : e` is deprecated. Use either `(a ? b : c) ? d : e` or `a ? b : (c ? d : e)` in include_once() (line 1439 of /home/science2016/public_html/includes/bootstrap.inc).
  • Deprecated function: Array and string offset access syntax with curly braces is deprecated in include_once() (line 3557 of /home/science2016/public_html/includes/bootstrap.inc).

Amidoxime-Functionalized (9,10-Dioxoantracen-1-yl)hydrazones

Maryna Stasevych1, Viktor Zvarych1, Volodymyr Novikov1, Mykhailo Vovk2
Affiliation: 
Lviv Polytechnic National University, 12, Bandera St., 79013 Lviv, Ukraine 2 Institute of Organic Chemistry of National Academy of Sciences of Ukraine, 5, Murmanska St., 02660 Kyiv, Ukraine  maryna.v.stasevych@gmail.com
DOI: 
https://doi.org/10.23939/chcht13.04.417
AttachmentSize
PDF icon full_text.pdf328.16 KB
Abstract: 
New (9,10-dioxoanthracen-1-yl)hydrazones containing amidoxime fragments were synthesized by the interaction of corresponding hydrazones of malonodinitrile, ethyl cyanacetate, ethyl acetoacetate, and acetylacetone with hydroxylamine in boiling dioxane in the presence of sodium acetate. It was established that the reaction of N-(9,10-dioxo-9,10-dihydroanthracen-1-yl)carbonohydrazonoyldicyanide 1 with NH2OH leads to the formation of 2-(2-(9,10-dioxo-9,10-dihydroanthracen-1-yl)hydrazinylidene)-N'1,N'3-dihydroxymalonimidamide 2 as the major product, and 3-amino-2-(2-(9,10-dioxo-9,10-dihydroanthracen-1-yl)hydrazinylidene)-3-(hydroxyimino)propanamide 3 as a minor product. The 1H, 13C NMR and LC-MS data showed that the interaction of 9,10-dioxoanthracenylhydrazone of acetylacetone 5 by hydroxylamine is accompanied with the elimination of the acetyl fragment formed 1-[2-(2-(hydroxyimino)propylidene)hydrazinyl]anthracene-9,10-dione 9. Possible mechanisms for the formation of amidoximes 3 and 9 are proposed. Quantum-chemical DFT calculations of the Gibbs free energy (G) to determine conformational advantage of Z- or E-isomers for the amidoxime form of the derivatives 2,3,7-9 were carried out using the M06-2X hybrid method with 6-311++G(d, p) basis set and the SMD solvation model in DMSO.
References: 

[1] Ahlam M.: Raf. Jour. Sci., 2008, 19, 59.
[2] Fylaktakidou K., Hadjipavlou-Litina D., Litinas K. et al.: Curr. Pharm. Des., 2008, 14, 1001. https://doi.org/10.2174/138161208784139675
[3] Katirtzi A.: Diploma Thesis, Charles University, 2015.
[4] Vaughan C.: Proc. Bayl. Univ. Med. Cent., 2005, 18, 76.
[5] Hawkins M., Lewis J.: Expert Opin. Drug Metab. Toxicol., 2012, 8, 1521. https://doi.org/10.1517/17425255.2012.724060
[6] Southworth H.: Statist. Med., 2014, 33, 2914. https://doi.org/10.1002/sim.6142
[7] Fontana R.: Gastroenterology, 2014, 146, 914. https://doi.org/10.1053/j.gastro.2013.12.032
[8] Van Ryn J., Stangier J., Haertter S. et al.: Thromb. Haemost., 2010, 103, 1116. https://doi.org/10.1160/TH09-11-0758
[9] Clement B., Kotthaus J., Kotthaus J., Schade D.: Pat. EP 2550966 A1 20130130, Publ. Jan. 30, 2013.
[10] Hall E., Kerrigan J., Ramachandran K. et al.: Antimicrob. Agents Chemother. 1998, 42, 666. https://doi.org/10.1128/AAC.42.3.666
[11] Schade D., Kotthaus J., Riebling L. et al.: J. Med. Chem. 2014, 57, 759. https://doi.org/10.1021/jm401492x
[12] Sperl S., Burgle M., Schmalix W. et al.: Pat. US 20060142305 A1 20060629, Publ. June 29, 2006.
[13] ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT01069965
[14] Frank P., Novak R.: Biochem. Pharmacol., 1985, 34, 3609. https://doi.org/10.1016/0006-2952(85)90744-0
[15] Gan K., Teng C., Lin H. et al.: Biol. Pharm. Bull., 2008, 31, 1547. https://doi.org/10.1248/bpb.31.1547
[16] Halenova T., Nikolaeva I., Stasevych M. et al.: Res. J. Pharm. Biol. Chem. Sci., 2017, 8, 1626.
[17] Zvarych V., Stasevych M., Lunin V. et al.: Monatsh. Chem., 2016, 147, 2093. https://doi.org/10.1007/s00706-016-1839-y
[18] Stasevych M., Zvarych V., Lunin V. et al.: Monatsh. Chem., 2018, 149, 1111. https://doi.org/10.1007/s00706-018-2157-3
[19] Zvarich V., Stasevich M., Stanko O. et al.: Pharm. Chem. J., 2014, 48, 584. https://doi.org/10.1007/s11094-014-1154-z
[20] Stasevych M., Zvarych V., Lunin V. et al.: Indian J. Pharm. Sci., 2015, 77, 634. https://doi.org/10.4103/0250-474X.169062
[21] Stasevych M., Zvarych V., Lunin V. et al.: SAR & QSAR in Environ. Res., 2017, 28, 355. https://doi.org/10.1080/1062936X.2017.1323796
[22] Stasevych M., Zvarych V., Musyanovych R. et al.: Chem. Chem. Technol., 2014, 8, 135. https://doi.org/10.23939/chcht08.02.135
[23] Stasevych M., Zvarych V., Lunin V. et al.: Chem. Chem. Technol., 2017, 11, 1. https://doi.org/10.23939/chcht11.01.001
[24] Stasevych M., Zvarych V., Khomyak S. et al.: Chem. Chem. Technol., 2018, 12, 300. https://doi.org/10.23939/chcht12.03.300
[25] Stasevych M., Zvarych V., Lunin V. et al.: Rus. J. Org. Chem., 2017, 53, 468. https://doi.org/10.1134/S1070428017030277
[26] Stasevych M., Zvarych V., Lunin V. et al.: Chem. Heterocycl. Compd., 2017, 53, 942. https://doi.org/10.1007/s10593-017-2148-z
[27] Gaussian 09, Revision B.01, Frisch M.J., Trucks G.W., Schlegel H.B. et al.: Gaussian, Inc., Wallingford CT, 2009.
[28] Exner O., Motekov N.: Collect. Czech. Chem. Commun. 1986, 51, 1444. https://doi.org/10.1135/cccc19861444
[29] Exner O.: Collect. Czech. Chem. Commun., 1965, 30, 652. https://doi.org/10.1135/cccc19650652
[30] Exner O., Motekov N.: Collect. Czech. Chem. Commun., 1978, 43, 2740. https://doi.org/10.1135/cccc19782740
[31] Tinant B., Dupont-Fenfau J., Declercq J.-P. et al.: Collect. Czech. Chem. Commun., 1989, 54, 3245. https://doi.org/10.1135/cccc19893245
[32] Srivastava R., Pereira M., Faustino W. et al.: Monatsh. Chem, 2009, 140, 1319. https://doi.org/10.1007/s00706-009-0186-7
[33] Vörös A., Mucsi Z., Baán Z. et al.: Org. Biomol. Chem., 2014, 12, 8036. https://doi.org/10.1039/C4OB00854E
[34] Rosenberg S., Silver S., Sayer J. et al.: J. Am. Chem. Soc., 1974, 96, 7986. https://doi.org/10.1021/ja00833a026
[35] Heckendorn R.: Bull. Soc. Chin. Belg. 1986, 95, 921. https://doi.org/10.1002/bscb.19860951101
[36] Novikov A., Bolotin D.: J. Phys. Org. Chem., 2017, e3772. https://doi.org/10.1002/poc.3772
[37] Bolotin D., Bokach N., Kukushkin V.: Coord. Chem. Rev., 2016, 313, 62. https://doi.org/10.1016/j.ccr.2015.10.005
[38] Tavakol H., Arshadi S.: J. Mol. Model., 2009, 15, 807. https://doi.org/10.1007/s00894-008-0435-4
[39] Su X., Aprahamian I.: Org. Lett., 2011, 13, 30. https://doi.org/10.1021/ol102422h
[40] Johnson J., Carvallo C., Dolliver D. et al.: Aust. J. Chem., 2007, 60, 685. https://doi.org/10.1071/CH07157